# Rebase Biotech, Inc — Form D

Rebase Biotech, Inc of DULUTH, MN, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-21. The offering totals $1.0M, of which $400K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-03-21
- Form: D
- Accession: 0001969987-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $400K
- Remaining: $600K
- Investors: 5
- Date of first sale: 2023-03-10
- Revenue range: Decline to Disclose
- SEC file number: 021-476405

## Issuer

- Name: Rebase Biotech, Inc
- CIK: 0001969987
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 1936 CHINOOK DR, DULUTH, MN, 55811
- Phone: 5135874000

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| SURESH MEREDDY | Executive Officer | BELLEVUE, WA |

## More

- [CIK 1969987 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1969987&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001969987-23-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.